Abstract
The amino-acid sequence of the Toho-1 β-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A β-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-β-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.
Original language | English |
---|---|
Pages (from-to) | 118-123 |
Number of pages | 6 |
Journal | Acta Crystallographica Section D: Structural Biology |
Volume | 76 |
DOIs | |
State | Published - Feb 1 2020 |
Funding
This research was sponsored by the Laboratory Directed Research and Development Program at Oak Ridge National Laboratory, which is managed by UT-Battelle LLC for the US Department of Energy (DOE). Research at ORNL’s Spallation Neutron Source was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy. The Office of Biological and Environmental Research supported research at Oak Ridge National Laboratory’s Center for Structural Molecular Biology (CSMB), using facilities supported by the Scientific User Facilities Division, Office of Basic Energy Sciences. This work was also supported in part through grant R01-GM071939 from the National Institutes of Health.
Funders | Funder number |
---|---|
Oak Ridge National Laboratory | |
Office of Basic Energy Sciences | |
Scientific User Facilities Division | |
US Department of Energy | |
UT-Battelle LLC | |
National Institutes of Health | |
U.S. Department of Energy | |
National Institute of General Medical Sciences | R01GM071939 |
Basic Energy Sciences | R01-GM071939 |
Oak Ridge National Laboratory | |
Canadian Society for Molecular Biosciences |
Keywords
- Toho-1
- X-ray diffraction
- antibiotics
- neutron diffraction
- β-lactamases